All Stories

  1. Rapid withdrawal of voxelotor can precipitate sickle cell disease related crisis
  2. A Systematic Review of Large Language Models in Medical Specialties: Applications, Challenges and Future Directions
  3. Immune reconstitution and survival, following hematopoietic stem cell transplantation in Omani patients with inborn errors of immunity
  4. Current Status and Management of Chronic Myeloid Leukemia in the Gulf Region: Survey Results and Expert Opinion
  5. The role of preoperative transfusion in sickle cell disease, a systematic review and meta-analysis
  6. CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA
  7. Multi-center study on mortality in children, and adults with sickle cell anemia-risk factors and causes of death
  8. Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry
  9. Appropriate Antiviral Therapy Can Prevent Hepatitis B Reactivation & Progression in Chronic Myeloid Leukemia on Therapy with Tyrosine Kinase Inhibitors
  10. Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently
  11. Differential Production of Midkine and Pleiotrophin by Innate APCs upon Stimulation through Nucleic Acid-Sensing TLRs
  12. Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East
  13. Artificial intelligence in sickle disease
  14. Influence of Voxelotor–hemoglobin complexes in the estimation of hemoglobin S levels by the current standard of care laboratory evaluation techniques
  15. The Role of Preoperative Transfusion in Sickle Cell Disease, a Systematic Review and Meta-Analysis
  16. ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS.
  17. Coexistence of sickle cell disease and systemic lupus erythematosus is associated with quantitative and qualitative impairments in circulating regulatory B cells
  18. Outcome of pregnancy in sickle cell anemia patients with COVID-19 infection
  19. Clinicopathological Profile of Paroxysmal Nocturnal Hemoglobinuria among Omani Patients: A Case Series
  20. The Challenges in Diagnosis and Management of Acquired Thrombotic Thrombocytopenic Purpura: Consensus Report from Three Gulf Countries
  21. Human macrophages and monocyte-derived dendritic cells stimulate the proliferation of endothelial cells through midkine production
  22. Transplant Associated Graft versus Host Disease
  23. Predicting risk factors for thromboembolic complications in patients with sickle cell anaemia – lessons learned for prophylaxis
  24. A reanalysis of pain crises data from the pivotal l-glutamine in sickle cell disease trial
  25. Iron Overload in Patients With Heavily Transfused Sickle Cell Disease—Correlation of Serum Ferritin With Cardiac T2* MRI (CMRTools), Liver T2* MRI, and R2-MRI (Ferriscan®)
  26. Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease
  27. Nutritional and Hematological Status of Sudanese Women of Childbearing Age with Steady-state Sickle Cell Anemia
  28. Impact of COVID-19 on vasooclusive crisis in patients with sickle cell anaemia
  29. Clinical and laboratory features of Hemoglobin La Desirade variant in association with sickle cell and alpha thalassemia genes
  30. Respiratory Viral Infections in Sickle Cell Anemia: Special Emphasis on H1N1 Co-infection
  31. Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study
  32. A A Multicentre ICET-A Study of Confirmed SARS-CoV-2 Infection in Patients with Hemoglobinopathies: Preliminary Data from 10 Countries
  33. Efficiency of day 4 compared to day 6 stem cell mobilization in allogeneic stem cell donors
  34. Hematopoietic stem cell transplantation for patients with sickle cell disease in the Eastern Mediterranean
  35. Unique aspects of Graft-versus-host-disease management in the Eastern Mediterranean region: Report from the Eastern Mediterranean blood and marrow transplantation group: Special report
  36. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations
  37. Predictors of impending acute chest syndrome in patients with sickle cell anaemia
  38. Clinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patients
  39. Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations
  40. PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
  41. Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group
  42. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
  43. THE USE OF HPLC AS A TOOL FOR NEONATAL CORD BLOOD SCREENING OF HAEMOGLOBINOPATHY - A VALIDATION STUDY
  44. Can Gestational Anemia be Alleviated with Increased Awareness of its Causes and Management Strategies? Implications for Health Care Services
  45. Stability of fetal hemoglobin levels in patients receiving metformin therapy
  46. A novel p.Pro353His SERPINC1 mutation in the thrombin-binding region affecting stability of Antithrombin molecule in an extended Omani family
  47. First Cytogenetic Profile of Omani Patients with de novo Myelodysplastic Syndromes: Comparison with data from Asia, Africa, Europe and North and South America
  48. Impact of Educational Activities in Reducing Pre-Analytical Laboratory Errors: A quality initiative
  49. Haemoglobin Fontainebleau (HBA2: c. 64G>C) in Oman: molecular and haematological characteristics and interaction with various haemoglobinopathies
  50. Therapeutic drug monitoring-guided dosing of busulfan differs from weight-based dosing in hematopoietic stem cell transplant patients
  51. INCREASED VASOOCCLUSIVE CRISIS IN “O” BLOOD GROUP SICKLE CELL DISEASE PATIENTS: ASSOCIATION WITH UNDERLYING THROMBOSPONDIN LEVELS.
  52. Regulatory B Cells Are Functionally Impaired in Patients Having Hemophilia A With Inhibitors
  53. Impact of Aberrant Myeloid Antigen Expression on Outcomes of Patients with T-cell Acute Lymphoblastic Leukemia
  54. ALLOIMMUNIZATION IN PATIENTS WITH SICKLE CELL DISEASE AND THALASSAEMIA: EXPERIENCE OF SINGLE CENTRE FROM OMAN
  55. Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures
  56. First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group
  57. First Implementation of Transfusion Consent Policy in Oman: Audit of compliance from a tertiary care university hospital
  58. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011–2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT)
  59. Accuracy of Platelet Counting by Optical and Impedance Methods in Patients with Thrombocytopaenia and Microcytosis
  60. Mode of delivery and risk of intracranial haemorrhage in newborns with severe haemophilia A: a multicentre study in Gulf region
  61. Duplication 1q as primary and 3q in t(3;13) as secondary aberration in Fanconi anemia: Implications and literature review
  62. SERUM TOTAL BILIRUBIN, NOT CHOLELITHIASIS, IS INFLUENCED BY UGT1A1 POLYMORPHISM, ALPHA THALASSEMIA AND S GENOTYPE: FIRST REPORT ON COMPARISON BETWEEN ARAB-INDIAN AND AFRICAN S GENES
  63. Aetiological profile of women presenting with premature ovarian failure to a single tertiary care center in Oman
  64. Biclonal Gammopathy in Chronic Lymphocytic Leukemia: Case Report and Review of the Literature
  65. Rituximab Leads to Long Remissions in Patients with Chronic Immune Thrombocytopenia
  66. Safety of stem cell mobilization in donors with sickle cell trait
  67. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies
  68. The pneumatic tube system does not affect complete blood count results; a validation study at a tertiary care hospital
  69. Epidemiology of chemotherapy-induced neutropenia at a tertiary university hospital in Oman
  70. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature
  71. A stepwise α-thalassemia screening strategy in high-prevalence areas
  72. Genital Ulcer Development in Patients with Acute Promyelocytic Leukaemia Treated with All-Trans Retinoic Acid: A Case Series
  73. Transcranial Doppler Ultrasonography in Sickle Cell Disease
  74. Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus
  75. Idiopathic thrombocytopenic purpura and hypokalaemic dRTA with compensated haemolysis and striking acanthocytosis in a band 3 (SLC4A1/AE1) A858D homozygote
  76. Coexistence of sickle cell disease and severe congenital neutropenia: first impressions can be deceiving
  77. Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients
  78. Complications of PORT-A-CATH® in patients with sickle cell disease
  79. dRTA and hemolytic anemia: first detailed description of SLC4A1 A858D mutation in homozygous state
  80. The β-globin promoter −71 C>T mutation is a β+ thalassemic allele
  81. Trends of Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region, 1984-2007
  82. Acute massive splenic infarction with complete liquefaction of the spleen in sickle cell disease
  83. Severity ranking of non-deletional alpha thalassemic alleles: insights from an Omani family study
  84. Sub-optimal serum gentamicin concentrations in sickle cell disease patients utilizing the Hartford protocol
  85. Complete recovery following sudden sensorineural hearing loss in a patient with sickle cell disease
  86. Hb Sheffield [β58(E2)Pro→His] in Oman: Potential Pitfall in Genetic Counseling
  87. Sensorineural hearing loss in sickle cell disease-A prospective study from Oman
  88. Clinical and laboratory characteristics of patients with sickle-cell and autoimmune/connective tissue diseases
  89. Predictive Value of Neutrophil to Lymphocyte Ratio in Outcomes of Patients with Acute Coronary Syndrome
  90. Coexistence of immune thrombocytopenic purpura and idiopathic membranous glomerulonephritis successfully treated with rituximab
  91. Review: Management of Painful Vaso-Occlusive Crisis of Sickle-Cell Anemia: Consensus Opinion
  92. Forecasting Hemoglobinopathy Burden Through Neonatal Screening in Omani Neonates
  93. Isochromosome 9q as a sole anomaly in an Omani boy with acute lymphoblastic leukaemia
  94. Splenectomy for haematological disorders: A single center study in 150 patients from Oman
  95. Orbital Infarction in Sickle Cell Disease
  96. Hematopoietic stem cell transplantation in Oman
  97. Arterial and Venous Thrombotic Complications with Thalidomide in Multiple Myeloma
  98. Complex t(8;13;21)(q22;q14;q22)–A Novel Variant of t(8;21) in a Patient with Acute Myeloid Leukemia (AML–M2)
  99. Familial lymphoma in an Omani kindred with identical class II HLA type
  100. Biphenotypic leukemia with interstitial del(9)(q22q32) as a sole abnormality
  101. Trisomy 21 as a Sole Acquired Abnormality in an Adult Omani Patient with CD7- and CD9-Positive Acute Myeloid Leukemia
  102. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia
  103. Sickle cell?haemoglobin E (HbSE) compound heterozygosity: a clinical and haematological study
  104. Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma
  105. Follicular dendritic cell hyperplasia in plasma cell variant of Castleman's disease with interfollicular Hodgkin's disease
  106. Recovery of normal autologous myelopoiesis after graft rejection following allogeneic bone marrow transplant for agnogenic myeloid metaplasia
  107. Hereditary thrombophilia in ethnic omani patients
  108. Successful outcome with anagrelide in pregnancy
  109. Imatinib in pregnancy
  110. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis
  111. Cytokine profile of sickle cell disease in Oman
  112. Cytokines in Sickle Cell Disease
  113. Erythroid hypoplasia associated with leptospirosis
  114. Orbital involvement in sickle cell disease: A report of five cases and review literature